Medizinische Hochschule Hannover (MHH) / Hannover Medical School
University / College
Location:
Hannover,
Germany (DE)
ISNI: 0000000095299877
ROR: https://ror.org/00f2yqf98
Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression (vol 25, pg 1551, 2014) (2017)
Nitz U, Gluz O, Huober J, Kreipe HH, Kates RE, Hartmann A, Erber R, et al.
Journal article
norUrsodeoxycholic acid (norUDCA) improves non-alcoholic fatty liver disease (NAFLD): Results from a randomized placebo-controlled, double-blind phase IIa study (2017)
Traussnigg S, Schattenberg JM, Demir M, Wiegand J, Geier A, Teuber G, Hofmann WP, et al.
Conference contribution
Fear of progression in patients with low-risk malignant melanoma (2017)
Wagner T, Augustin M, Blome C, Forschner A, Garbe C, Gutzmer R, Hauschild A, et al.
Conference contribution
Interleukin-2 and Checkpoint Inhibition as a successful Therapy Sequence for metastatic Melanoma: Case Report and retrospective Analysis in 52 Patients (2017)
Cosgarea , Zimmer L, Weide B, Gutzmer R, Heinzerling L, Weishaupt C, Pfoehler C, et al.
Conference contribution
News from the Contact Allergy - Overview and Discussion of interesting Publications from 2016 (2017)
Uter W, Werfel T
Journal article
A multidisciplinary systematic review of the treatment for chronic idiopathic tinnitus (2017)
Zenner HP, Delb W, Kroener-Herwig B, Jaeger B, Peroz I, Hesse G, Mazurek B, et al.
Journal article
Intermediate Follow-up of Pediatric Patients With Hemolytic Uremic Syndrome During the 2011 Outbreak Caused by E. coli O104:H4 (2017)
Loos S, Aulbert W, Hoppe B, Ahlenstiel-Grunow T, Kranz B, Wahl C, Staude H, et al.
Journal article
CD14 Plays a Protective Role in Experimental Inflammatory Bowel Disease by Enhancing Intestinal Barrier Function (2017)
Buchheister S, Buettner M, Basic M, Noack A, Breves G, Buchen B, Keubler LM, et al.
Journal article
Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study (2017)
Feagan BG, Sandborn WJ, D'Haens G, Panes J, Kaser A, Ferrante M, Louis E, et al.
Journal article
Graft Growth and Podocyte Dedifferentiation in Donor-Recipient Size Mismatch Kidney Transplants (2017)
Müller-Deile J, Braesen JH, Pollheimer M, Ratschek M, Haller H, Pape L, Schiffer M
Journal article